Molecular determinants of steroid recognition and catalysis in aldo- keto reductases. Lessons from 3α-hydroxysteroid dehydrogenase

Journal of Steroid Biochemistry and Molecular Biology

Volumn 69, Issue 1-6, 1999, Pages 211-225

  Penning, T M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20ALPHA HYDROXYSTEROID DEHYDROGENASE; 3ALPHA HYDROXYSTEROID DEHYDROGENASE; HYDROXYSTEROID DEHYDROGENASE; STEROID 5BETA REDUCTASE; TRYPTOPHAN;

CARBOXY TERMINAL SEQUENCE; CATALYSIS; CLUSTER ANALYSIS; CONFERENCE PAPER; ENZYME ACTIVITY; HUMAN; LIGAND BINDING; MOLECULAR RECOGNITION; MUTAGENESIS; NONHUMAN; SITE DIRECTED MUTAGENESIS;

3-ALPHA-HYDROXYSTEROID DEHYDROGENASE (B-SPECIFIC); 3-HYDROXYSTEROID DEHYDROGENASES; ALCOHOL OXIDOREDUCTASES; ANIMALS; CATALYSIS; HUMANS; MULTIGENE FAMILY; MUTAGENESIS, SITE-DIRECTED; STEROIDS; SUBSTRATE SPECIFICITY;

EID: 0033051603     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00038-2     Document Type: Conference Paper

References (59)

1. Lin H-K., Jez J.M., Schlegel B.P., Peehl D.M., Pachter J.A., Penning T.M. Expression and characterization of recombinant type 2 3α-hydroxysteroid dehydrogenase (HSD) from human prostate. Demonstration of bifunctional 3α/17β-HSD activity and cellular distribution. Mol. Endocrinol. 11:1997;1971-1984.
2. Funder J.W., Pearce P.T., Smith R., Smith A.I. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 242:1998;583-585.
3. Stewart P.M., Whorwood C.B. 11β-hydroxysteroid dehydrogenase activity and corticosteroid hormone action. Steroids. 59:1994;90-95.
4. Albiston A.L., Obeyesekere V.R., Smith R.E., Krozowski Z.S. Cloning and tissue distribution of the human 11-HSD type 2 enzyme. Mol. Cell. Endocrinol. 105:1994;R11-R17.
5. Adams E.F., Coldham N.G., James V.H. Steroidal regulation of oestradiol-17β dehydrogenase activity of the human breast cancer cell line MCF-7. J. Endocrinol. 118:1988;149-154.
6. Reed M.J., Singh A., Ghilchik M.W., Coldham N.G., Purohit A. Regulation of oestradiol 17β-hydroxysteroid dehydrogenase in breast tissues: the role of growth factors. J. Steroid Biochem. Mol. Biol. 39:1991;791-798.
7. Luu-The V., Labrie C., Zhao H.F., Couet J., Lachance Y., Simard J., Leblanc G., Cote J., Berube D., Gagne R., Labrie F. Characterization of cDNAs for human estradiol 17β-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5′-termini in human placenta. Mol. Endocrinol. 3:1989;1301-1309.
8. Andersson S., Geissler W.M., Patel S., Wu L. The molecular biology of androgenic 17β-hydroxysteroid dehydrogenases. J. Steroid Biochem. Mol. Biol. 53:1995;37-39.
9. Labrie F., Luu-The V., Lin S-X., Labrie C., Simard J., Breton R., Belanger A. The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology. Steroids. 62:1997;148-158.
10. + oxidoreductase of rat ventral prostate. Biochemistry. 14:1975;810-817.
11. Jacobi G.H., Moore R.J., Wilson J.D. Characterization of the 3α-hydroxysteroid dehydrogenase of dog prostate. J. Steroid Biochem. 8:1977;719-723.
12. Jacobi G.H., Wilson J.D. The formation of 5α-androstane-3α,17β-diol by dog prostate. Endocrinology. 99:1976;602-610.
13. Jacobi G.H., Moore R.J., Wilson J.D. Studies on the mechanism of 3α-androstanediol-induced growth of the dog prostate. Endocrinology. 102:1978;1748-1758.
14. Isaacs J.T. Changes in dihydrotestosterone metabolism and the development of benign prostatic hyperplasia in the aging beagle. J. Steroid Biochem. 18:1983;749-757.
15. Biswas M.G., Russell D.W. Expression cloning and characterization of oxidative 17β- and 3α-hydroxysteroid dehydrogenases from rat and human prostate. J. Biol. Chem. 272:1997;15,959-15,966.
16. A receptor. Science. 232:1986;1004-1007.
17. A receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 38:1992;379-395.
18. A receptor complex: electrophysiological studies. Steroids and Neuronal Activity. Ciba Foundation Symposium. vol. 153:1990;56-82 Wiley, Chichester.
19. A receptor function. Trends Pharmacol. Sci. 16:1995;295-303.
20. Mahendroo M., Cala K.M., Russell D.W. 5α-Reduced androgens play a key role in murine parturition. Mol. Endocrinol. 10:1996;380-392.
21. Wiest W.G., Wilcox R.B. Purification and properties of rat ovarian 20α-hydroxysteroid dehydrogenase. J. Biol. Chem. 236:1961;2425-2428.
22. Mori M., Wiest W.G. Purification of rat ovary 20α-hydroxysteroid dehydrogenase by affinity chromatography. J. Steroid Biochem. 11:1979;1443-1449.
23. Jornvall H., Persson B., Krook M., Atrian S., Gonzalez-Duarte R., Jeffery J., Ghosh D. Short-chain dehydrogenases/reductases (SDR). Biochemistry. 34:1995;6003-6013.
24. Baker M.E., Fanestil D.D. Licorice, computer-based analyses of dehydrogenase sequences, and the regulation of steroid and prostaglandin action. Mol. Cell. Endocrinol. 78:1991;C99-102.
25. Baker M.E. Unusual evolution of 11β-hydroxysteroid and retinol dehydrogenases. Bioessays. 18:1996;63-70.
26. Azzi A., Rehse P.H., Zhu D-W., Campbell R., Labrie F., Lin S-X. Crystal structure of human estrogenic 17β-hydroxysteroid dehydrogenase complexed with 17β-estradiol. Nature Structure Biology. 3:1996;665-668.
27. + identifies two principal targets for the design of inhibitors. Structure. 4:1996;905-915.
28. Pawlowski J.E., Huizinga M., Penning T.M. Cloning and sequencing of the cDNA for rat liver 3α-hydroxysteroid/dihydrodiol dehydrogenase. J. Biol. Chem. 266:1991;8820-8825.
29. Stolz A., Rahimi-Kiani M., Ameis D., Chan E., Ronk M., Shively J.E. Molecular structure of rat hepatic 3α-hydroxysteroid dehydrogenase. A member of the oxidoreductase gene family. J. Biol. Chem. 266:1991;15,253-15,257.
30. Cheng K.C., White P.C., Qin K.N. Molecular cloning and expression of rat liver 3α-hydroxysteroid dehydrogenase. Mol. Endocrinol. 5:1991;823-828.
31. Khanna M., Qin K.N., Wang R.W., Cheng K.C. Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3α-hydroxysteroid dehydrogenases. J. Biol. Chem. 270:1995;20,162-20,168.
32. Miura R., Shiota K., Noda K., Yagi S., Ogawa T., Takahashi M. Molecular cloning of cDNA for rat ovarian 20α-hydroxysteroid dehydrogenase (HSD1). Biochem. J. 299:1994;561-567.
33. Lacy W.R., Washenick K.J., Cook R.G., Dunbar B.S. Molecular cloning and expression of an abundant rabbit ovarian protein with 20α-hydroxysteroid dehydrogenase activity. Mol. Endocrinol. 7:1993;58-66. (published erratum appears in Mol. Endocrinol. 1993 Sep;7(9):1239).
34. Jez J.M., Flynn T.G., Penning T.M. A new nomenclature for the aldo-keto reductase superfamily. Biochem. Pharmacol. 53:1997.
35. Deyashiki Y., Ogasawara A., Nakayama T., Nakanishi M., Miyabe Y., Sato K., Hara A. Molecular cloning of two human liver 3α-hydroxysteroid/dihydrodiol dehydrogenase isoenzymes that are identical with chlordecone reductase and bile-acid binder. Biochem. J. 299:1994;545-552.
36. Stolz A., Hammond L., Lou H., Takikawa H., Ronk M., Shively J.E. cDNA cloning and expression of the human hepatic bile acid-binding protein. A member of the monomeric reductase gene family. J. Biol. Chem. 268:1993;10,448-10,457.
37. Warren J.C., Murdock G.L., Ma Y., Goodman S.R., Zimmer W.E. Molecular cloning of testicular 20α-hydroxysteroid dehydrogenase: identity with aldose reductase. Biochemistry. 32:1993;1401-1406.
38. Deyashiki Y., Ohshima K., Nakanishi M., Sato K., Matsuura K., Hara A. Molecular cloning and characterization of mouse estradiol 17β-dehydrogenase (A-specific), a member of the aldoketoreductase family. J. Biol. Chem. 270:1995;10,461-10,467.
39. 4-ketosteroid-5β-reductase of rat liver. FEBS Letters. 238:1994;215-218.
40. 4-3-oxosteroid-5β-reductase and substrate specificity of the expressed enzyme. Eur. J. Biochem. 219:1994;357-363.
41. Tomlinson D.R., Stevens E.J., Diemel L.T. Aldose reductase inhibitors and their potential for the treatment of diabetic complications. Trends in Pharmacol. Sci. 15:1972;293-297.
42. Turner A.J., Illingworth J.A., Tipton K.F. Simulation of biogenic amine metabolism in the brain. Biochem. J. 144:1972;353-360.
43. Penning T.M., Mukharji I., Barrows S., Talalay P. Purification and properties of a 3α-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs. Biochem. J. 222:1984;601-611.
44. Pawlowski J.E., Penning T.M. Overexpression and mutagenesis of the cDNA for rat liver 3α-hydroxysteroid/dihydrodiol dehydrogenase. Role of cysteines and tyrosines in catalysis. J. Biol. Chem. 269:1994;13,502-13,510.
45. Askonas L.J., Ricigliano J.W., Penning T.M. The kinetic mechanism catalysed by homogeneous rat liver 3α-hydroxysteroid dehydrogenase. Evidence for binary and ternary dead-end complexes containing non-steroidal anti-inflammatory drugs. Biochem. J. 278:1991;835-841.
46. Hoog S.S., Pawlowski J.E., Alzari P.M., Penning T.M., Lewis M. Three-dimensional structure of rat liver 3α-hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily. Proc. Natl. Acad. Sci. USA. 91:1994;2517-2521.
47. +. Biochemistry. 35:1996;10,702-10,711.
48. + bound to 3α-hydroxysteroid/dihydrodiol dehydrogenase. Structure. 5:1997;799-812.
49. Wilson D.K., Bohren K.M., Gabbay K.H., Quiocho F.A. An unlikely sugar substrate site in the 1.65 Å structure of the human aldose reductase holoenzyme implicated in diabetic complications. Science. 257:1992;81-84.
50. Schlegel B.P., Ratnam K., Penning T.M. Retention of NADPH-linked quinone reductase activity in an aldo-keto reductase following mutation of the catalytic tyrosine. Biochemistry. 37:1998;11003-11011.
51. Schlegel B.P., Jez J.M., Penning T.M. Mutagenesis of 3α-hydroxysteroid dehydrogenase reveals a'push-pull' mechanism for proton transfer in aldo-keto reductases. Biochemistry. 37:1998;3538-3548.
52. Jez J.M., Penning T.M. Engineering steroid 5β-reductase activity into rat liver 3α-hydroxysteroid dehydrogenase. Biochemistry. 37:1998;9605-9703.
53. 4-3-ketosteroid 5β-reductase. J. Biol. Chem. 259:1984;7519-7524.
54. Jez J.M., Schlegel B.P., Penning T.M. Characterization of the substrate binding site in rat liver 3α-hydroxysteroid dehydrogenase: the roles of tryptophans in ligand binding and protein fluorescence. J. Biol. Chem. 271:1996;30,190-30,198.
55. Mylari B.L., Larson E.R., Beyer T.A., Zembrowski W.J., Aldinger C.E., Dee M.F., Siegel T.W., Singleton D.H. Novel potent ADR inhibitors 3,4-dihydro-4-oxo-3[(5-(trifluoromethyl)-2-benzothiazoyl)methyl]-1- phthalazineacetic acid (zopolrestat) and its congeners. J. Med. Chem. 34:1991;108-122.
56. Ward W.H.J., Sennitt C.M., Ross H., Dingle A., Timms D., Mirrlees D.J., Tuffin D.P. Ponalrestat - a potent and specific inhibitor of aldose reductase. Biochem. Pharmacol. 39:1990;337-346.
57. Ricigliano J.W., Penning T.M. Synthesis and evaluation of nonsteroidal mechanism-based inactivators of 3α-hydroxysteroid dehydrogenase. Biochem. J. 269:1989;139-149.
58. Schlegel B.P., Pawlowski J.E., Hu Y., Scolnick D.M., Covey D.F., Penning T.M. Secosteroid mechanism-based inactivators and site-directed mutagenesis as probes for steroid hormone recognition by 3α-hydroxysteroid dehydrogenase. Biochemistry. 33:1994;10,367-10,374.
59. Cleland W.W. Statistical analysis of enzyme kinetic data. Methods Enz. 63:1979;103-138.